2016
DOI: 10.7554/elife.11685
|View full text |Cite
|
Sign up to set email alerts
|

Allosteric modulation in monomers and oligomers of a G protein-coupled receptor

Abstract: The M2 muscarinic receptor is the prototypic model of allostery in GPCRs, yet the molecular and the supramolecular determinants of such effects are unknown. Monomers and oligomers of the M2 muscarinic receptor therefore have been compared to identify those allosteric properties that are gained in oligomers. Allosteric interactions were monitored by means of a FRET-based sensor of conformation at the allosteric site and in pharmacological assays involving mutants engineered to preclude intramolecular effects. E… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
27
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(29 citation statements)
references
References 27 publications
(72 reference statements)
2
27
0
Order By: Relevance
“…Communication between protomers resulting in asymmetric properties among receptor molecules within small oligomers such as dimers and tetramers has been documented for both rhodopsin and other GPCRs [25, 28, 76, 77]. For some GPCRs, this communication within a dimer or tetramer appears to play a central role in receptor signaling and underlies the efficacy of the system [78, 79].…”
Section: Discussionmentioning
confidence: 99%
“…Communication between protomers resulting in asymmetric properties among receptor molecules within small oligomers such as dimers and tetramers has been documented for both rhodopsin and other GPCRs [25, 28, 76, 77]. For some GPCRs, this communication within a dimer or tetramer appears to play a central role in receptor signaling and underlies the efficacy of the system [78, 79].…”
Section: Discussionmentioning
confidence: 99%
“…within the seven TM), whereas, in class C GPCR, the two sites are usually well separated (see Wu et al, 2014). When a receptor complex forms, the allosteric binding sites on single monomers may undergo structural and functional changes (see Shivnaraine et al, 2016). Of significant interest, however, is the possibility that, when the complex forms, the quaternary structure could display novel specific allosteric sites suitable for the binding of some modulator.…”
Section: Quaternary Structure Of Gpcr Complexesmentioning
confidence: 99%
“…It has been shown that the presence of one protomer can alter membrane localization (Ellis et al, 2006;Rozenfeld et al, 2012), the affinity and/or efficacy of agonists (Martin and Prather, 2001;Rozenfeld et al, 2012;Wang et al, 2005), and signaling specificity (Charles et al, 2003;Rozenfeld et al, 2012) for the other promoter. Moreover, ligand binding to the orthosteric site of one promoter can change the pharmacological properties of orthosteric ligands for the other protomer (Ferre et al, 2016;Shivnaraine et al, 2016;Vischer et al, 2011). For example, apelin binding to its receptor reduces the binding and efficacy of angiotensin II acting at the angiotensin II Type 1 receptor via negative cooperativity between the protomers of the heteromer (Siddiquee et al, 2013).…”
Section: Introductionmentioning
confidence: 99%